Wolfe Research started Syneos Health with a Peer Perform rating and $53 price target, stating that while the stock trades at a meaningful discount to peers the firm doesn’t have the conviction to step in given that results and stock performance to date have been highly volatile.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.